Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers

Documenti analoghi

• Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers
  di: Cossu MV, et al.
  Pubblicazione: (2014-05-01)
• Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans
  di: Sciorati, Clara, et al.
  Pubblicazione: (2010)
• A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy
  di: Sciorati, Clara, et al.
  Pubblicazione: (2011)
• Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers.
  di: Wallén, N H, et al.
  Pubblicazione: (1993)
• Saliva concentrations of isosorbide dinitrate, isosorbide 2-mononitrate and isosorbide 5-mononitrate.
  di: Taylor, I W, et al.
  Pubblicazione: (1984)